Pitolisant (CED0009287)

Record Information
Version1.0
Creation Date2026-04-14 18:18:50 UTC
Update Date2026-05-14 19:11:09 UTC
SynCED IDCED0009287
Secondary Accession Numbers
  • CHEM131286
Identification
Common NamePitolisant
ClassSmall Molecule
Description
Pitolisant is an organic compound with the formula C17H26ClNO and an average molecular weight of 295.85 g/mol. Pitolisant belongs to the halobenzenes, a subclass of benzene and substituted derivatives within the organic compounds. This compound is found in or released from healthcare, pharmaceuticals, and veterinary products, specifically categorized as unclassified nervous system drugs, and is administered via the oral exposure route. Pitolisant acts on two recorded protein targets: it serves as an antagonist and inverse agonist/blocker of the Histamine H3 receptor (HRH3), and it targets the voltage-gated inwardly rectifying potassium channel KCNH2.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC17H26ClNO
Average Molecular Mass295.850 g/mol
Monoisotopic Mass295.170 g/mol
CAS Registry Number362665-56-3
IUPAC NameNot Available
Traditional NameNot Available
SMILESClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
InChI IdentifierInChI=1S/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2
InChI KeyNNACHAUCXXVJSP-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0002-9700000000-3dbad73168be1a49e119Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0002-0590000000-81de9a6a39c65fd0dcefNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0f92-6920000000-9c9a86f5250502935877Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0f96-9700000000-bce3092a44893f241028Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0006-0490000000-07c881bceeacb79cc9c1Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-000x-4930000000-77ebf455bd0ade37ad3aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-9500000000-fa417cfa87d3c1e8a33dNot AvailableView Spectrum
Toxicity Profile
Toxicity ValuesNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000384Unclassified nervous system drugs?Unclassified nervous system drugs encompass a wide range of synthetic chemicals that are designed to affect the central and peripheral nervous systems.Healthcare, pharmaceuticals & veterinary productsNot Available
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Histamine H3 receptor structureClick to view 3D structureHistamine H3 receptorQ9Y5N1HumansPredicted (SEA)
Prediction Confidence Score
0.706
Applicability Domain
1.0
Statistical Significance
5.00e-05
Supporting Reference Compounds
294
E-value
0.389246
Histamine H1 receptor structureClick to view 3D structureHistamine H1 receptorP35367HumansPredicted (SEA)
Prediction Confidence Score
0.664
Applicability Domain
1.0
Statistical Significance
2.00e-04
Supporting Reference Compounds
507
E-value
1.55698
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)
Prediction Confidence Score
0.578
Applicability Domain
0.971
Statistical Significance
8.00e-04
Supporting Reference Compounds
562
E-value
6.22794
Click to view 3D structureSigma non-opioid intracellular receptor 1Q60492Cavia porcellusPredicted (SEA)
Prediction Confidence Score
0.571
Applicability Domain
1.0
Statistical Significance
8.90e-04
Supporting Reference Compounds
229
E-value
6.92858
Click to view 3D structureHistamine H3 receptorQ9JI35Cavia porcellusPredicted (SEA)
Prediction Confidence Score
0.556
Applicability Domain
1.0
Statistical Significance
1.40e-04
Supporting Reference Compounds
56
E-value
1.08989
Click to view 3D structureCholinesteraseP81908Equus caballusPredicted (SEA)
Prediction Confidence Score
0.55
Applicability Domain
1.0
Statistical Significance
0.0011
Supporting Reference Compounds
201
E-value
8.32987
Click to view 3D structureHistamine H3 receptorQ9QYN8Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.539
Applicability Domain
1.0
Statistical Significance
3.10e-04
Supporting Reference Compounds
80
E-value
2.41333
Click to view 3D structureSigma intracellular receptor 2Q5BJF2HumansPredicted (SEA)
Prediction Confidence Score
0.538
Applicability Domain
0.971
Statistical Significance
5.60e-04
Supporting Reference Compounds
308
E-value
4.35956
Voltage-gated inwardly rectifying potassium channel KCNH2 structureClick to view 3D structureVoltage-gated inwardly rectifying potassium channel KCNH2Q12809HumansPredicted (SEA)
Prediction Confidence Score
0.537
Applicability Domain
1.0
Statistical Significance
0.0036
Supporting Reference Compounds
1498
E-value
27.87
Click to view 3D structureSigma intracellular receptor 2Q5U3Y7Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.518
Applicability Domain
1.0
Statistical Significance
4.60e-04
Supporting Reference Compounds
110
E-value
3.58106
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansPredicted (SEA)
Prediction Confidence Score
0.499
Applicability Domain
0.971
Statistical Significance
0.0036
Supporting Reference Compounds
823
E-value
27.7922
5-hydroxytryptamine receptor 7 structureClick to view 3D structure5-hydroxytryptamine receptor 7P34969HumansPredicted (SEA)
Prediction Confidence Score
0.498
Applicability Domain
0.971
Statistical Significance
0.003
Supporting Reference Compounds
565
E-value
23.6662
Sodium-dependent noradrenaline transporter structureClick to view 3D structureSodium-dependent noradrenaline transporterP23975HumansPredicted (SEA)
Prediction Confidence Score
0.497
Applicability Domain
0.971
Statistical Significance
0.0011
Supporting Reference Compounds
451
E-value
8.40772
Histamine H4 receptor structureClick to view 3D structureHistamine H4 receptorQ9H3N8HumansPredicted (SEA)
Prediction Confidence Score
0.488
Applicability Domain
1.0
Statistical Significance
5.60e-04
Supporting Reference Compounds
150
E-value
4.35956
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)
Prediction Confidence Score
0.444
Applicability Domain
0.49
Statistical Significance
0.0095
Supporting Reference Compounds
861
E-value
74.1903
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP28223HumansPredicted (SEA)
Prediction Confidence Score
0.444
Applicability Domain
0.49
Statistical Significance
0.0107
Supporting Reference Compounds
955
E-value
83.6101
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)
Prediction Confidence Score
0.444
Applicability Domain
0.49
Statistical Significance
0.0138
Supporting Reference Compounds
1103
E-value
107.121
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)
Prediction Confidence Score
0.444
Applicability Domain
0.49
Statistical Significance
0.0112
Supporting Reference Compounds
953
E-value
87.5025
Click to view 3D structureD(4) dopamine receptorP30729Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.444
Applicability Domain
0.49
Statistical Significance
0.0011
Supporting Reference Compounds
92
E-value
8.25202
Muscarinic acetylcholine receptor M4 structureClick to view 3D structureMuscarinic acetylcholine receptor M4P08173HumansPredicted (SEA)
Prediction Confidence Score
0.432
Applicability Domain
0.971
Statistical Significance
0.0013
Supporting Reference Compounds
297
E-value
10.5096
D(1B) dopamine receptor structureClick to view 3D structureD(1B) dopamine receptorP21918HumansPredicted (SEA)
Prediction Confidence Score
0.416
Applicability Domain
0.468
Statistical Significance
0.0034
Supporting Reference Compounds
209
E-value
26.3909
D(1A) dopamine receptor structureClick to view 3D structureD(1A) dopamine receptorP21728HumansPredicted (SEA)
Prediction Confidence Score
0.416
Applicability Domain
0.468
Statistical Significance
0.0062
Supporting Reference Compounds
425
E-value
48.5779
Acetylcholinesterase structureClick to view 3D structureAcetylcholinesteraseP22303HumansPredicted (SEA)
Prediction Confidence Score
0.416
Applicability Domain
0.537
Statistical Significance
0.0068
Supporting Reference Compounds
406
E-value
53.171
Click to view 3D structureHistamine H3 receptorP58406Mus musculusPredicted (SEA)
Prediction Confidence Score
0.414
Applicability Domain
1.0
Statistical Significance
3.00e-05
Supporting Reference Compounds
17
E-value
0.233548
Sodium-dependent serotonin transporter structureClick to view 3D structureSodium-dependent serotonin transporterP31645HumansPredicted (SEA)
Prediction Confidence Score
0.387
Applicability Domain
0.431
Statistical Significance
0.0126
Supporting Reference Compounds
593
E-value
97.7786
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available